The products are preloaded and ready to use, providing surgeons with flexibility for various applications. Credit: PopTika / Shutterstock.

Medical device company Biocomposites is set to commence UK distribution of its NanoBone product range.

The range includes NanoBone SBX Putty and NanoBone QD, the next-generation synthetic bone grafts designed for early osteogenesis and bone formation.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

NanoBone’s patented technology features nanostructured hydroxyapatite within a silica gel matrix, suspended in a hydrogel / polymer silica carrier.

This composition supports bone regeneration, offering a healing rate comparable to autografts and osteoinductive properties, without the associated costs and harvesting complications.

The products are preloaded and ready to use, providing surgeons with flexibility and efficiency for various applications.

See Also:

Biocomposites managing director Dr Walter Gerike said: “NanoBone is a proven technology that has already helped over 100,000 patients throughout the world.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The UK is a significant market and we are very pleased to start selling our innovative range of ready-to-use products there. This development furthers Biocomposites’ position as the go-to provider for surgeons requiring advanced bone regeneration materials.”

The company will unveil the product range at the British Orthopaedic Association’s Annual Congress 2024 in Birmingham, UK.

Last year, Biocomposites acquired German company Artoss, adding the latter’s NanoBone range to its portfolio.

Artoss is a manufacturer of bone graft substitutes for use in orthopaedics, spine, foot and ankle, and dentistry.

With the acquisition, Artoss offers its NanoBone technology and products such as SBX Putty to Biocomposites global distribution network allowing them to reach surgeons and patients in more than 40 countries.

Biocomposites is engaged in engineering, manufacturing and marketing products for use in infection management in bone and soft tissue.

The UK-based company has operations across Europe, South America, Canada, the US, China and India.